Today: 1 July 2026
Browse Category

NYSE:MRNA 22 June 2025

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Biotechnology is at the forefront of scientific innovation in 2025, driven by companies around the world that are transforming healthcare, agriculture, and industry. This report profiles 100 of the most important global biotechnology companies selected for their global impact, innovation, revenue, scientific breakthroughs, and sector influence. These companies span biopharmaceutical giants, genomics and diagnostics pioneers, agricultural and environmental biotech leaders, industrial biotech innovators, and key providers of biotech tools and services. Each entry includes the company’s headquarters country, primary sector, notable contributions or innovations, and a link to its official website. The list encompasses both publicly traded and private firms, reflecting the worldwide landscape of biotech innovation. Selection Criteria: Companies were chosen based on their demonstrated leadership or innovation in their field, significant contributions to science and health, financial strength, and influence within their sector. The selection emphasizes current industry positioning and breakthroughs – from life-saving vaccines and therapies to cutting-edge genomic technologies and sustainable biological solutions.

Stock Market Today

  • Enviri (NVRI) Jumps 100% After Spin-Off, CEO Talks Next Steps
    July 1, 2026, 4:11 PM EDT. Enviri Corporation (NYSE:NVRI) is up 100% since it spun off its environmental and rail units on June 2. Quarterly revenue hit $550 million, while the company posted a small GAAP loss of $8 million and $65 million in operating income. CEO Nick Grasberger said Enviri is making progress on selling Clean Earth and finishing up division splits, moves he says are key to unlocking value. But with NVRI's big rally and fresh strategy, some investors may stick with AI stocks, which offer faster growth and maybe less risk. Enviri's overhaul sets up more changes, but investors will want to compare NVRI against other choices.
Go toTop